Even though it is still early days, the revascularization of damaged cardiac tissue following acute myocardial infarction with transplanted cells, is currently being transformed from a research concept to a clinical tool. Moreover, research work continues for the treatment of heart failure and some cardiomyopathies. Various tissue types and genes are transplanted to help improve left ventricular and systolic scar functions, and to prevent further deterioration of ejection fractions. The editors, have assembled a top-rate team of international researchers and clinicians, to offer their experience in transplanting tissues to damaged hearts with the strategy of providing safe, beneficial repair of damaged myocardium and enhancing angiogenesis in ischemic myocardium. Doris A Taylor, Department of Cardiology, Duke University Medical Center, Durham, USA, Ewout J van den Bos, Department of Cardiology, Duke University Medical Center, Durham, USA, E Mi
Professor Serruys has written over 30 books.